Raymzon Trade Links Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Net Worth 67.42%
(FY 2022)
- Total Assets 1826.42%
(FY 2022)
About Raymzon Trade Links
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tarsem Ruby, Veeta Sharma, and Shivansh Sharma serve as directors at the Company.
- CIN/LLPIN
U33100CH2020PTC043139
- Company No.
043139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Raymzon Trade Links?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivansh Sharma  | Director | 06-Aug-2020 | Current |
| Tarsem Ruby | Director | 06-Aug-2020 | Current |
| Veeta Sharma | Director | 06-Aug-2020 | Current |
Financial Performance of Raymzon Trade Links.
Raymzon Trade Links Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 67.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Raymzon Trade Links?
Unlock access to Raymzon Trade Links's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Raymed Pharmaceuticals LimitedActive 30 years 7 daysTarsem Ruby, Veeta Sharma and 1 more are mutual person
Raymed Ophthalmic Private LimitedActive 5 years 8 monthsTarsem Ruby and Shivansh Sharma are mutual person
- Aquavision Pharmaceuticals Private LimitedActive 4 years 3 months
Tarsem Ruby and Shivansh Sharma are mutual person
- Ayuray Organics Private LimitedActive 4 years 6 months
Tarsem Ruby and Shivansh Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raymzon Trade Links?
Raymzon Trade Links has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raymzon Trade Links, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raymzon Trade Links's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
